Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine

Francisco Perez-Duran,Fernando Calderon-Rico,Luis Enrique Franco-Correa,Alicia Gabriela Zamora-Aviles,Roberto Ortega-Flores,Daniel Durand-Herrera,Alejandro Bravo-Patiño,Ricarda Cortes-Vieyra,Ilane Hernandez-Morales,Rosa Elvira Nuñez-Anita
DOI: https://doi.org/10.3390/vaccines12060652
2024-06-12
Vaccines
Abstract:The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and respiratory syndrome virus (PRRSV). For inoculation, twenty-one-day-old pigs were allocated into six groups: control, vehicle, vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated with activate adaptive cellular immunity, IL-1β (1.15 ± 1.15 to 10.17 ± 0.94 pg/mL) and IL-12 (323.8 ± 23.3 to 778.5 ± 58.11 pg/mL), compared to the control group. The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi compared to that at 0 days (128.3 ± 8.34 ng/mL to 231.9 ± 17.82 and 331 ± 14.86 ng/mL), while IgGs anti-GP5-B3 increased at 21 dpi (105.1 ± 19.06 to 178 ± 15.09 ng/mL) and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21−) increased in both cases (9.85 ± 0.7% to 13.67 ± 0.44 for GP5-B and 15.72 ± 1.27% for GP5-B3). Furthermore, primed B cells (CD2−/CD21+) from immunized pigs showed an increase in both cases (9.62 ± 1.5% to 24.51 ± 1.3 for GP5-B and 34 ± 2.39% for GP5-B3) at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the control group (8.84 ± 0.63% to 6.25 ± 0.66 for GP5-B and 5.78 ± 0.48% for GP5-B3). Importantly, both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from the vaccinated group, as well as the non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen-specific IgGs and B cell activation.
immunology,medicine, research & experimental
What problem does this paper attempt to address?
The main objective of this paper is to investigate the immune response elicited by two synthetic peptides derived from the GP5 protein of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) (GP5-B and GP5-B3) in pigs, particularly focusing on the role of linear B-cell epitopes in humoral immunity and B-cell-mediated immune responses. Specifically, the study explored the immunogenicity of these two peptides through the following aspects: 1. **Changes in inflammatory cytokine levels**: Two days post-inoculation, the GP5-B3 peptide significantly increased the concentrations of cytokines IL-1β and IL-12 in pig serum, which are associated with the activation of adaptive cellular immunity. 2. **Production of specific IgG antibodies**: The GP5-B peptide significantly increased the concentration of anti-GP5-B IgG at 21 days and 42 days post-inoculation; whereas the GP5-B3 peptide significantly increased the concentration of anti-GP5-B3 IgG only at 21 days, and this level remained unchanged at 42 days. 3. **Changes in B-cell subsets**: Following inoculation with these two peptides, the proportions of plasma cells (CD2+/CD21−) and activated B cells (CD2−/CD21+) significantly increased, while the proportion of naive B cells (CD2+/CD21+) decreased. 4. **In vitro immunoreactivity**: Both GP5-B and GP5-B3 peptides were able to react with serum antibodies from naturally infected pigs and pigs inoculated with a modified live vaccine (MLV), indicating that the B-cell epitopes contained in these peptides may be conserved in wild-type strains. In summary, this study aims to evaluate the potential of GP5-B and GP5-B3 peptides as vaccine candidates, particularly in their role in inducing an effective humoral immune response against PRRSV.